ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The genetic or cytogenetic confirmation of Ph + and/or BCR-ABL1 fusion status was available for 33 % of CML diagnoses made in 2000–2004, 83 % in 2005–2009 and 82 % in 2010–2013 period.